tuberostemonine has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Liu, S; Pan, T; Qi, X; Su, S; Sun, M; Zhou, L | 1 |
1 other study(ies) available for tuberostemonine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Tuberostemonine alleviates high-fat diet-induced obesity and hepatic steatosis by increasing energy consumption.
Topics: Alkaloids; Animals; Diet, High-Fat; Lipid Metabolism; Lipids; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2023 |